ID
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
sequence | ner_tags
sequence |
|---|---|---|---|---|---|
NCT01312857 | 37:62:cancer,63:86:cancer,132:152:chronic_disease | History of histologically confirmed colorectal adenocarcinoma metastatic to the liver with no clinical or radiographic evidence of extrahepatic disease | 3 | [
"History",
"of",
"histologically",
"confirmed",
"colorectal",
"adenocarcinoma",
"metastatic",
"to",
"the",
"liver",
"with",
"no",
"clinical",
"or",
"radiographic",
"evidence",
"of",
"extrahepatic",
"disease"
] | [
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01312857 | 44:62:cancer,64:72:chronic_disease,107:122:treatment,138:144:chronic_disease | Patients with history or known presence of primary CNS tumors, seizures not well controlled with standard medical therapy, or history of stroke will also be excluded | 3 | [
"Patients",
"with",
"history",
"or",
"known",
"presence",
"of",
"primary",
"CNS",
"tumors",
",",
"seizures",
"not",
"well",
"controlled",
"with",
"standard",
"medical",
"therapy",
",",
"or",
"history",
"of",
"stroke",
"will",
"also",
"be",
"excluded"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
2,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
NCT01306045 | 36:66:chronic_disease,101:116:treatment,138:153:treatment,155:180:treatment,206:233:chronic_disease | Patients with any condition (e.g., gastrointestinal tract disease resulting in an inability to take oral medication or a requirement for IV alimentation, prior surgical procedures affecting absorption, or active peptic ulcer disease) that impairs their ability to swallow and retain tablets | 3 | [
"Patients",
"with",
"any",
"condition",
"(",
"e.g.",
",",
"gastrointestinal",
"tract",
"disease",
"resulting",
"in",
"an",
"inability",
"to",
"take",
"oral",
"medication",
"or",
"a",
"requirement",
"for",
"IV",
"alimentation",
",",
"prior",
"surgical",
"procedures",
"affecting",
"absorption",
",",
"or",
"active",
"peptic",
"ulcer",
"disease",
")",
"that",
"impairs",
"their",
"ability",
"to",
"swallow",
"and",
"retain",
"tablets"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01306019 | 123:131:chronic_disease,140:146:chronic_disease,148:155:chronic_disease,254:259:chronic_disease,278:288:chronic_disease | Auto- or allo-immunity: Examples must include objective physical findings that include, but are not limited to any one of alopecia, severe rashes, uveitis, joint pain with redness or swelling or limitation of movement that is not a result of infection, lupus-like lesions, and granulomas | 3 | [
"Auto-",
"or",
"allo-immunity",
":",
"Examples",
"must",
"include",
"objective",
"physical",
"findings",
"that",
"include",
",",
"but",
"are",
"not",
"limited",
"to",
"any",
"one",
"of",
"alopecia",
",",
"severe",
"rashes",
",",
"uveitis",
",",
"joint",
"pain",
"with",
"redness",
"or",
"swelling",
"or",
"limitation",
"of",
"movement",
"that",
"is",
"not",
"a",
"result",
"of",
"infection",
",",
"lupus-like",
"lesions",
",",
"and",
"granulomas"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
2
] |
NCT01306019 | 1:27:chronic_disease,6:15:chronic_disease,31:36:chronic_disease,,, | Skin molluscum contagiosum OR warts (this criterion is satisfied if molluscum consists of greater than or equal to 10 lesions or there are two or more lesions at each of two or more widely separated anatomic sites; or there are greater than or equal to 3 warts at different anatomic sites at the same time; or the patient has both molluscum and warts) | 3 | [
"Skin",
"molluscum",
"contagiosum",
"OR",
"warts",
"(",
"this",
"criterion",
"is",
"satisfied",
"if",
"molluscum",
"consists",
"of",
"greater",
"than",
"or",
"equal",
"to",
"10",
"lesions",
"or",
"there",
"are",
"two",
"or",
"more",
"lesions",
"at",
"each",
"of",
"two",
"or",
"more",
"widely",
"separated",
"anatomic",
"sites",
";",
"or",
"there",
"are",
"greater",
"than",
"or",
"equal",
"to",
"3",
"warts",
"at",
"different",
"anatomic",
"sites",
"at",
"the",
"same",
"time",
";",
"or",
"the",
"patient",
"has",
"both",
"molluscum",
"and",
"warts",
")"
] | [
2,
2,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01280994 | 25:58:treatment,74:79:treatment,,99:102:treatment | Subject has received an investigational medicinal product (not including 129Xe) within 30 days of MRI | 3 | [
"Subject",
"has",
"received",
"an",
"investigational",
"medicinal",
"product",
"(",
"not",
"including",
"129Xe",
")",
"within",
"30",
"days",
"of",
"MRI"
] | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1
] |
NCT01280669 | 16:26:treatment,,69:83:treatment,95:121:treatment | combination of prednisone <10 mg/day (or equivalent dose of another corticosteroid) and other systemic immunosuppressant | 3 | [
"combination",
"of",
"prednisone",
"<",
"10",
"mg/day",
"(",
"or",
"equivalent",
"dose",
"of",
"another",
"corticosteroid",
")",
"and",
"other",
"systemic",
"immunosuppressant"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1,
1
] |
NCT01270724 | 32:38:cancer,42:59:cancer,78:101:treatment | Patients with the diagnosis of mature or immature teratoma in the absence of tumor marker elevations | 3 | [
"Patients",
"with",
"the",
"diagnosis",
"of",
"mature",
"or",
"immature",
"teratoma",
"in",
"the",
"absence",
"of",
"tumor",
"marker",
"elevations"
] | [
0,
0,
0,
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
1,
1,
1
] |
NCT01261728 | 7:41:chronic_disease,45:86:chronic_disease,112:128:chronic_disease | Known human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS)-related illness or other active infection | 3 | [
"Known",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"or",
"acquired",
"immunodeficiency",
"syndrome",
"(",
"AIDS",
")",
"-related",
"illness",
"or",
"other",
"active",
"infection"
] | [
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT01261728 | 1:22:chronic_disease,31:46:chronic_disease,48:87:treatment,89:125:chronic_disease,127:151:chronic_disease,155:180:chronic_disease,185:203:chronic_disease | myocardial infarction, severe/unstable angina, coronary/peripheral artery bypass graft, symptomatic congestive heart failure, cerebrovascular accident or transient ischemic attack, or pulmonary embolism | 3 | [
"myocardial",
"infarction",
",",
"severe/unstable",
"angina",
",",
"coronary/peripheral",
"artery",
"bypass",
"graft",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"cerebrovascular",
"accident",
"or",
"transient",
"ischemic",
"attack",
",",
"or",
"pulmonary",
"embolism"
] | [
2,
2,
0,
2,
2,
0,
1,
1,
1,
1,
0,
2,
2,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
0,
2,
2
] |
NCT01245712 | 56:78:chronic_disease,80:95:chronic_disease,97:112:chronic_disease,117:139:chronic_disease,236:241:cancer | Palpable or radiographically suspicious ipsilateral or contralateral axillary, supraclavicular, infraclavicular, or internal mammary nodes at time of enrollment unless there is histologic confirmation that these nodes are negative for tumor | 3 | [
"Palpable",
"or",
"radiographically",
"suspicious",
"ipsilateral",
"or",
"contralateral",
"axillary",
",",
"supraclavicular",
",",
"infraclavicular",
",",
"or",
"internal",
"mammary",
"nodes",
"at",
"time",
"of",
"enrollment",
"unless",
"there",
"is",
"histologic",
"confirmation",
"that",
"these",
"nodes",
"are",
"negative",
"for",
"tumor"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT01245712 | ,,41:54:cancer,59:67:cancer,73:78:cancer, | The patient must have stage 0, I, or II breast cancer; if stage II, the tumor size must be 3 cm or less | 3 | [
"The",
"patient",
"must",
"have",
"stage",
"0",
",",
"I",
",",
"or",
"II",
"breast",
"cancer",
";",
"if",
"stage",
"II",
",",
"the",
"tumor",
"size",
"must",
"be",
"3",
"cm",
"or",
"less"
] | [
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT01239095 | 19:25:treatment,33:38:cancer,42:55:cancer | Patient must have biopsy proven colon or rectal cancer | 3 | [
"Patient",
"must",
"have",
"biopsy",
"proven",
"colon",
"or",
"rectal",
"cancer"
] | [
0,
0,
0,
1,
0,
3,
0,
3,
3
] |
NCT01220583 | 10:29:cancer,38:66:cancer,,127:158:cancer,160:171:cancer,176:182:cancer | No prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 3 years (for example, carcinoma in situ of the breast, oral cavity, or cervix are all permissible) | 3 | [
"No",
"prior",
"invasive",
"malignancy",
"(",
"except",
"non-melanomatous",
"skin",
"cancer",
")",
"unless",
"disease",
"free",
"for",
"a",
"minimum",
"of",
"3",
"years",
"(",
"for",
"example",
",",
"carcinoma",
"in",
"situ",
"of",
"the",
"breast",
",",
"oral",
"cavity",
",",
"or",
"cervix",
"are",
"all",
"permissible",
")"
] | [
0,
0,
3,
3,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
3,
0,
3,
3,
0,
0,
3,
0,
0,
0,
0
] |
NCT01220583 | 43:66:cancer,,129:139:treatment,166:172:treatment | Radiologic confirmation of the absence of hematogenous metastasis within 12 weeks prior to registration; at a minimum, contrast CT imaging of the chest is required (PET/CT is acceptable) | 3 | [
"Radiologic",
"confirmation",
"of",
"the",
"absence",
"of",
"hematogenous",
"metastasis",
"within",
"12",
"weeks",
"prior",
"to",
"registration",
";",
"at",
"a",
"minimum",
",",
"contrast",
"CT",
"imaging",
"of",
"the",
"chest",
"is",
"required",
"(",
"PET/CT",
"is",
"acceptable",
")"
] | [
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT01185210 | 1:11:treatment,19:31:treatment,33:48:treatment,50:67:treatment,69:81:treatment | GI surgery except appendectomy, cholecystectomy, caesarean section, hysterectomy | 3 | [
"GI",
"surgery",
"except",
"appendectomy",
",",
"cholecystectomy",
",",
"caesarean",
"section",
",",
"hysterectomy"
] | [
1,
1,
0,
1,
0,
1,
0,
1,
1,
0,
1
] |
NCT01185132 | 15:39:cancer,43:54:treatment,105:112:treatment | Subjects with malignant calcifications on mammography will be required to have repeat mammography after surgery to ensure removal of all malignant calcifications | 3 | [
"Subjects",
"with",
"malignant",
"calcifications",
"on",
"mammography",
"will",
"be",
"required",
"to",
"have",
"repeat",
"mammography",
"after",
"surgery",
"to",
"ensure",
"removal",
"of",
"all",
"malignant",
"calcifications"
] | [
0,
0,
3,
3,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT01175044 | 15:40:chronic_disease,50:53:chronic_disease,54:58:chronic_disease | Patients with chronic immunosuppression (such as HIV/AIDS) | 3 | [
"Patients",
"with",
"chronic",
"immunosuppression",
"(",
"such",
"as",
"HIV/AIDS",
")"
] | [
0,
0,
2,
2,
0,
0,
0,
2,
0
] |
NCT01174121 | 15:43:cancer,63:74:treatment,78:88:treatment | Patients with metastatic colorectal cancer must have received oxaliplatin or irinotecan | 3 | [
"Patients",
"with",
"metastatic",
"colorectal",
"cancer",
"must",
"have",
"received",
"oxaliplatin",
"or",
"irinotecan"
] | [
0,
0,
3,
3,
3,
0,
0,
0,
1,
0,
1
] |
NCT01174108 | 1:42:chronic_disease,76:86:chronic_disease,95:104:chronic_disease | Paroxysmal nocturnal hemoglobinuria (PNH) associated with life-threatening thrombosis, and/or cytopenia, and/or transfusion dependence and/or recurrent and debilitating hemolytic crisis | 3 | [
"Paroxysmal",
"nocturnal",
"hemoglobinuria",
"(",
"PNH",
")",
"associated",
"with",
"life-threatening",
"thrombosis",
",",
"and/or",
"cytopenia",
",",
"and/or",
"transfusion",
"dependence",
"and/or",
"recurrent",
"and",
"debilitating",
"hemolytic",
"crisis"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01174108 | 1:29:chronic_disease,33:60:chronic_disease,133:144:treatment,204:229:treatment | Severe aplastic anemia (SAA) or pure red cell aplasia (PRCA [acquired or congenital]) associated with transfusion dependence and/or neutropenia in patients who are not candidates for, or who have failed immunosuppressive therapy | 3 | [
"Severe",
"aplastic",
"anemia",
"(",
"SAA",
")",
"or",
"pure",
"red",
"cell",
"aplasia",
"(",
"PRCA",
"[",
"acquired",
"or",
"congenital",
"]",
")",
"associated",
"with",
"transfusion",
"dependence",
"and/or",
"neutropenia",
"in",
"patients",
"who",
"are",
"not",
"candidates",
"for",
",",
"or",
"who",
"have",
"failed",
"immunosuppressive",
"therapy"
] | [
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01130077 | 22:30:treatment,32:40:treatment,42:51:treatment | Growth factors (e.g. Procrit®, Aranesp®, Neulasta®) | 3 | [
"Growth",
"factors",
"(",
"e.g",
".",
"Procrit®",
",",
"Aranesp®",
",",
"Neulasta®",
")"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT01130077 | 43:49:chronic_disease,82:94:treatment,111:120:treatment | Newly diagnosed, non-brainstem high-grade glioma* Patients may not have received chemotherapy during or after radiation | 3 | [
"Newly",
"diagnosed",
",",
"non-brainstem",
"high-grade",
"glioma",
"*",
"Patients",
"may",
"not",
"have",
"received",
"chemotherapy",
"during",
"or",
"after",
"radiation"
] | [
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
1
] |
NCT01130077 | 24:31:cancer,,64:76:treatment,77:94:treatment,127:136:treatment, | Unresectable low-grade gliomas that have received at least two chemotherapy/biologic regimens. Patients may not have received radiation to the index lesion within 1 year of enrollment | 3 | [
"Unresectable",
"low-grade",
"gliomas",
"that",
"have",
"received",
"at",
"least",
"two",
"chemotherapy/biologic",
"regimens",
".",
"Patients",
"may",
"not",
"have",
"received",
"radiation",
"to",
"the",
"index",
"lesion",
"within",
"1",
"year",
"of",
"enrollment"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01128816 | 14:25:treatment,29:40:treatment,44:70:treatment | Hypertrophic obstructive or restrictive or post partum cardiomyopathy | 3 | [
"Hypertrophic",
"obstructive",
"or",
"restrictive",
"or",
"post",
"partum",
"cardiomyopathy"
] | [
0,
1,
0,
1,
0,
1,
1,
1
] |
NCT01101451 | 15:34:chronic_disease,78:91:chronic_disease,93:109:treatment | Patients with renal abnormalities requiring modification of radiation field (pelvic kidney, renal transplant, etc.) | 3 | [
"Patients",
"with",
"renal",
"abnormalities",
"requiring",
"modification",
"of",
"radiation",
"field",
"(",
"pelvic",
"kidney",
",",
"renal",
"transplant",
",",
"etc",
".",
")"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT01099644 | 1:14:treatment,,63:79:treatment,84:97:treatment | Prior Therapy: At least 4 weeks should have elapsed since any biologic therapy, or immunotherapy | 3 | [
"Prior",
"Therapy",
":",
"At",
"least",
"4",
"weeks",
"should",
"have",
"elapsed",
"since",
"any",
"biologic",
"therapy",
",",
"or",
"immunotherapy"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
1
] |
NCT01096368 | 64:87:cancer,111:130:cancer,134:165:cancer | Patients must be newly diagnosed with histologically confirmed intracranial ependymoma; patients with classic ependymoma (WHO II) or anaplastic ependymoma (WHO III) are eligible, as are various subtypes described as clear cell, papillary, cellular or a combination of the above | 3 | [
"Patients",
"must",
"be",
"newly",
"diagnosed",
"with",
"histologically",
"confirmed",
"intracranial",
"ependymoma",
";",
"patients",
"with",
"classic",
"ependymoma",
"(",
"WHO",
"II",
")",
"or",
"anaplastic",
"ependymoma",
"(",
"WHO",
"III",
")",
"are",
"eligible",
",",
"as",
"are",
"various",
"subtypes",
"described",
"as",
"clear",
"cell",
",",
"papillary",
",",
"cellular",
"or",
"a",
"combination",
"of",
"the",
"above"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01087294 | 23:27:chronic_disease,60:70:chronic_disease,75:87:chronic_disease,101:135:treatment, | Either no evidence of GVHD or minimal clinical evidence of acute GVHD and chronic GVHD while off of systemic immunosuppressive therapy for at least 28 days | 3 | [
"Either",
"no",
"evidence",
"of",
"GVHD",
"or",
"minimal",
"clinical",
"evidence",
"of",
"acute",
"GVHD",
"and",
"chronic",
"GVHD",
"while",
"off",
"of",
"systemic",
"immunosuppressive",
"therapy",
"for",
"at",
"least",
"28",
"days"
] | [
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT01087294 | 1:14:treatment,16:50:treatment,58:70:treatment,,112:152:treatment,170:179:treatment, | Prior Therapy: Therapy with monoclonal antibodies and/or chemotherapy must be stopped at least 7 days prior to anti-CD19 CAR-transduced T cell infusion, and recovery of treatment-associated toxicity to less than or equal to grade 2 is required prior to infusion of cells | 3 | [
"Prior",
"Therapy",
":",
"Therapy",
"with",
"monoclonal",
"antibodies",
"and/or",
"chemotherapy",
"must",
"be",
"stopped",
"at",
"least",
"7",
"days",
"prior",
"to",
"anti-CD19",
"CAR-transduced",
"T",
"cell",
"infusion",
",",
"and",
"recovery",
"of",
"treatment-associated",
"toxicity",
"to",
"less",
"than",
"or",
"equal",
"to",
"grade",
"2",
"is",
"required",
"prior",
"to",
"infusion",
"of",
"cells"
] | [
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01061515 | 48:73:cancer,86:96:cancer,100:126:cancer | Patients must have a histologically documented peritoneal carcinomatosis from either colorectal or appendiceal adenocarcinoma | 3 | [
"Patients",
"must",
"have",
"a",
"histologically",
"documented",
"peritoneal",
"carcinomatosis",
"from",
"either",
"colorectal",
"or",
"appendiceal",
"adenocarcinoma"
] | [
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
3,
0,
3,
3
] |
NCT01061515 | 48:59:allergy_name,61:72:allergy_name,74:78:allergy_name,82:94:allergy_name | Prior history of hypersensitivity reactions to oxaliplatin, bevacizumab, 5-FU or capecitabine | 3 | [
"Prior",
"history",
"of",
"hypersensitivity",
"reactions",
"to",
"oxaliplatin",
",",
"bevacizumab",
",",
"5-FU",
"or",
"capecitabine"
] | [
0,
0,
0,
0,
0,
0,
4,
0,
4,
0,
4,
0,
4
] |
NCT01059786 | 47:58:treatment,64:73:treatment,81:93:treatment | Patients with history of non-response to both pentostatin plus rituximab and to bendamustine plus rituximab | 3 | [
"Patients",
"with",
"history",
"of",
"non-response",
"to",
"both",
"pentostatin",
"plus",
"rituximab",
"and",
"to",
"bendamustine",
"plus",
"rituximab"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
0,
0
] |
NCT01054196 | 102:114:allergy_name,126:137:allergy_name,142:151:allergy_name | History of allergic reactions attributed to compounds of similar chemical or biologic composition to lenalidomide (including thalidomide) or melphalan | 3 | [
"History",
"of",
"allergic",
"reactions",
"attributed",
"to",
"compounds",
"of",
"similar",
"chemical",
"or",
"biologic",
"composition",
"to",
"lenalidomide",
"(",
"including",
"thalidomide",
")",
"or",
"melphalan"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
4,
0,
0,
4,
0,
0,
4
] |
NCT01050855 | 14:23:chronic_disease,25:31:chronic_disease,41:51:chronic_disease | Uncontrolled bacterial, fungal or viral infections | 3 | [
"Uncontrolled",
"bacterial",
",",
"fungal",
"or",
"viral",
"infections"
] | [
0,
2,
0,
2,
0,
0,
2
] |
NCT01042522 | ,47:54:treatment,79:96:treatment,98:105:treatment,114:127:treatment | Patients must be entered within 8 weeks after surgery performed for either 1) initial diagnosis, staging, and/or cytoreduction, or 2) (if done) management of recurrent disease in a chemonaive patient | 3 | [
"Patients",
"must",
"be",
"entered",
"within",
"8",
"weeks",
"after",
"surgery",
"performed",
"for",
"either",
"1",
")",
"initial",
"diagnosis",
",",
"staging",
",",
"and/or",
"cytoreduction",
",",
"or",
"2",
")",
"(",
"if",
"done",
")",
"management",
"of",
"recurrent",
"disease",
"in",
"a",
"chemonaive",
"patient"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01042522 | 40:61:cancer,63:83:cancer,85:115:cancer,117:142:cancer,144:157:cancer,160:186:cancer,188:204:cancer,219:241:cancer,243:257:cancer | Patients with histologically confirmed ovarian stromal tumor [granulosa cell tumor, ganulosa cell-theca cell tumor, Sertoli-Leydig cell tumor (androblastoma), steroid (lipid) cell tumor, gynandroblastoma, unclassified sex cord-stromal tumor, sex cord tumor with annular tubules] | 3 | [
"Patients",
"with",
"histologically",
"confirmed",
"ovarian",
"stromal",
"tumor",
"[",
"granulosa",
"cell",
"tumor",
",",
"ganulosa",
"cell-theca",
"cell",
"tumor",
",",
"Sertoli-Leydig",
"cell",
"tumor",
"(",
"androblastoma",
")",
",",
"steroid",
"(",
"lipid",
")",
"cell",
"tumor",
",",
"gynandroblastoma",
",",
"unclassified",
"sex",
"cord-stromal",
"tumor",
",",
"sex",
"cord",
"tumor",
"with",
"annular",
"tubules",
"]"
] | [
0,
0,
0,
0,
3,
3,
3,
0,
3,
3,
3,
0,
3,
3,
3,
3,
0,
3,
3,
3,
0,
3,
0,
0,
3,
3,
3,
3,
0,
0,
0,
3,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01037790 | 15:19:cancer,35:41:cancer,54:65:treatment,93:100:treatment,158:167:treatment | Patients with HER2-overexpressing tumors may receive trastuzumab up to the date of starting therapy, and may continue to receive trastuzumab while receiving PD0332991 | 3 | [
"Patients",
"with",
"HER2-overexpressing",
"tumors",
"may",
"receive",
"trastuzumab",
"up",
"to",
"the",
"date",
"of",
"starting",
"therapy",
",",
"and",
"may",
"continue",
"to",
"receive",
"trastuzumab",
"while",
"receiving",
"PD0332991"
] | [
0,
0,
3,
3,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01026532 | 7:22:chronic_disease,31:49:chronic_disease,51:64:chronic_disease,66:88:chronic_disease,90:115:chronic_disease,119:132:chronic_disease,144:150:chronic_disease | Major health problems such as autoimmune disease, heart disease, type I and II diabetes, uncontrolled hypertension or lung diseases other than asthma. The listed health problems are definitive exclusion but decisions regarding major health problems not listed will be based upon the judgment of the investigator | 3 | [
"Major",
"health",
"problems",
"such",
"as",
"autoimmune",
"disease",
",",
"heart",
"disease",
",",
"type",
"I",
"and",
"II",
"diabetes",
",",
"uncontrolled",
"hypertension",
"or",
"lung",
"diseases",
"other",
"than",
"asthma",
".",
"The",
"listed",
"health",
"problems",
"are",
"definitive",
"exclusion",
"but",
"decisions",
"regarding",
"major",
"health",
"problems",
"not",
"listed",
"will",
"be",
"based",
"upon",
"the",
"judgment",
"of",
"the",
"investigator"
] | [
0,
2,
2,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
2,
2,
0,
2,
2,
0,
2,
2,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01011777 | 23:37:treatment,72:87:treatment,91:97:treatment | Previous injection of bulking agents at the level of the bladder neck (bovine collagen or DEFLUX™) | 3 | [
"Previous",
"injection",
"of",
"bulking",
"agents",
"at",
"the",
"level",
"of",
"the",
"bladder",
"neck",
"(",
"bovine",
"collagen",
"or",
"DEFLUX™",
")"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0
] |
NCT00977977 | 22:31:chronic_disease,35:63:chronic_disease,94:106:treatment | Clinical evidence of cirrhosis or chronic active liver disease sufficiently severe to impair cyclosporine metabolism; this would include a prolonged prothrombin time | 3 | [
"Clinical",
"evidence",
"of",
"cirrhosis",
"or",
"chronic",
"active",
"liver",
"disease",
"sufficiently",
"severe",
"to",
"impair",
"cyclosporine",
"metabolism",
";",
"this",
"would",
"include",
"a",
"prolonged",
"prothrombin",
"time"
] | [
0,
0,
0,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00977977 | 28:39:chronic_disease,114:123:treatment,186:206:chronic_disease | Patients with a history of arrhythmias will be evaluated by a cardiology consultant regarding recommendations as Rituximab has been reported to exacerbate arrhythmias (in patients with rheumatoid arthritis) | 3 | [
"Patients",
"with",
"a",
"history",
"of",
"arrhythmias",
"will",
"be",
"evaluated",
"by",
"a",
"cardiology",
"consultant",
"regarding",
"recommendations",
"as",
"Rituximab",
"has",
"been",
"reported",
"to",
"exacerbate",
"arrhythmias",
"(",
"in",
"patients",
"with",
"rheumatoid",
"arthritis",
")"
] | [
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT00969332 | 1:8:allergy_name,10:13:allergy_name,18:26:allergy_name | Seafood, egg, or Omegaven allergy | 3 | [
"Seafood",
",",
"egg",
",",
"or",
"Omegaven",
"allergy"
] | [
4,
0,
4,
0,
0,
4,
0
] |
NCT00967577 | 78:90:cancer,99:114:cancer,159:175:treatment,192:217:treatment | Histologically, or cytologically documented, advanced stage, malignant adult solid tumors (except prostate cancer) that are refractory to, or recurrent from, standard therapy or for which no curative standard therapy exists | 3 | [
"Histologically",
",",
"or",
"cytologically",
"documented",
",",
"advanced",
"stage",
",",
"malignant",
"adult",
"solid",
"tumors",
"(",
"except",
"prostate",
"cancer",
")",
"that",
"are",
"refractory",
"to",
",",
"or",
"recurrent",
"from",
",",
"standard",
"therapy",
"or",
"for",
"which",
"no",
"curative",
"standard",
"therapy",
"exists"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
1,
1,
1,
0
] |
NCT00967577 | 1:69:treatment,76:85:treatment,88:97:treatment | Prior treatment with 89Strontium or 153Samarium containing compounds (e.g. Metastron®, Quadramet®) | 3 | [
"Prior",
"treatment",
"with",
"89Strontium",
"or",
"153Samarium",
"containing",
"compounds",
"(",
"e.g",
".",
"Metastron®",
",",
"Quadramet®",
")"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
1,
0
] |
NCT00967577 | 8:22:treatment,26:47:treatment,,66:75:treatment | Use of red blood cell or platelet transfusions within 4 weeks of treatment | 3 | [
"Use",
"of",
"red",
"blood",
"cell",
"or",
"platelet",
"transfusions",
"within",
"4",
"weeks",
"of",
"treatment"
] | [
0,
0,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
1
] |
NCT00959140 | 1:4:cancer,20:29:treatment,34:49:treatment | AML: Refractory to Induction and salvage therapy | 3 | [
"AML",
":",
"Refractory",
"to",
"Induction",
"and",
"salvage",
"therapy"
] | [
3,
0,
0,
0,
1,
0,
1,
1
] |
NCT00930228 | 24:56:chronic_disease,83:107:chronic_disease,109:115:chronic_disease,148:163:treatment | Significant history of cardiac or pulmonary dysfunction (e.g., known or suspected congestive heart failure; asthma requiring intermittent systemic corticosteroids; etc.) | 3 | [
"Significant",
"history",
"of",
"cardiac",
"or",
"pulmonary",
"dysfunction",
"(",
"e.g.",
",",
"known",
"or",
"suspected",
"congestive",
"heart",
"failure",
";",
"asthma",
"requiring",
"intermittent",
"systemic",
"corticosteroids",
";",
"etc",
".",
")"
] | [
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT00929006 | 13:25:chronic_disease,33:62:chronic_disease,64:86:chronic_disease,88:101:chronic_disease | Evidence of virilization (e.g., rapidly progressive hirsutism, deepening of the voice, clitoromegaly) | 3 | [
"Evidence",
"of",
"virilization",
"(",
"e.g.",
",",
"rapidly",
"progressive",
"hirsutism",
",",
"deepening",
"of",
"the",
"voice",
",",
"clitoromegaly",
")"
] | [
0,
0,
2,
0,
0,
0,
2,
2,
2,
0,
2,
2,
2,
2,
0,
2,
0
] |
NCT00929006 | 1:19:chronic_disease,,62:64:chronic_disease,65:69:chronic_disease, | Hyperprolactinemia: Mild prolactin elevations may be seen in HA/PCOS, and elevations within 20% higher than the upper limit of normal will be accepted in this group | 3 | [
"Hyperprolactinemia",
":",
"Mild",
"prolactin",
"elevations",
"may",
"be",
"seen",
"in",
"HA/PCOS",
",",
"and",
"elevations",
"within",
"20",
"%",
"higher",
"than",
"the",
"upper",
"limit",
"of",
"normal",
"will",
"be",
"accepted",
"in",
"this",
"group"
] | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00928356 | 16:45:treatment,60:63:treatment,86:98:treatment | Requirement of revascularization of arteries amendable for PCI but not accessable by Robotic CABG | 3 | [
"Requirement",
"of",
"revascularization",
"of",
"arteries",
"amendable",
"for",
"PCI",
"but",
"not",
"accessable",
"by",
"Robotic",
"CABG"
] | [
0,
0,
1,
1,
1,
0,
0,
1,
0,
0,
0,
0,
1,
1
] |
NCT00924027 | 52:70:chronic_disease,86:93:chronic_disease,95:104:chronic_disease,106:113:chronic_disease,123:140:chronic_disease,264:271:treatment | Clinically significant unrelated systemic illness (serious infections or significant cardiac, pulmonary, hepatic or other organ dysfunction), which in the judgment of the Principal or Associate Investigator would compromise the patient s ability to tolerate this therapy or are likely to interfere with the study procedures or results | 3 | [
"Clinically",
"significant",
"unrelated",
"systemic",
"illness",
"(",
"serious",
"infections",
"or",
"significant",
"cardiac",
",",
"pulmonary",
",",
"hepatic",
"or",
"other",
"organ",
"dysfunction",
")",
",",
"which",
"in",
"the",
"judgment",
"of",
"the",
"Principal",
"or",
"Associate",
"Investigator",
"would",
"compromise",
"the",
"patient",
"s",
"ability",
"to",
"tolerate",
"this",
"therapy",
"or",
"are",
"likely",
"to",
"interfere",
"with",
"the",
"study",
"procedures",
"or",
"results"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
0,
2,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00924027 | 15:50:cancer,59:72:treatment,106:129:treatment,141:152:treatment | Patients with localized prostate cancer (T1b-T3b) in whom brachytherapy will be integrated as a boost to external beam radiation or used as monotherapy for definitive management | 3 | [
"Patients",
"with",
"localized",
"prostate",
"cancer",
"(",
"T1b-T3b",
")",
"in",
"whom",
"brachytherapy",
"will",
"be",
"integrated",
"as",
"a",
"boost",
"to",
"external",
"beam",
"radiation",
"or",
"used",
"as",
"monotherapy",
"for",
"definitive",
"management"
] | [
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
1,
0,
0,
0
] |
NCT00919503 | 15:41:chronic_disease,26:41:chronic_disease,46:60:chronic_disease,109:150:chronic_disease,154:188:chronic_disease | Patients with idiopathic aplastic anemia and Fanconi anemia; (patients with aplastic anemia associated with paroxysmal nocturnal hemoglobinuria [PNH] or inherited marrow failure syndromes, except Fanconi anemia, will be allowed) | 3 | [
"Patients",
"with",
"idiopathic",
"aplastic",
"anemia",
"and",
"Fanconi",
"anemia",
";",
"(",
"patients",
"with",
"aplastic",
"anemia",
"associated",
"with",
"paroxysmal",
"nocturnal",
"hemoglobinuria",
"[",
"PNH",
"]",
"or",
"inherited",
"marrow",
"failure",
"syndromes",
",",
"except",
"Fanconi",
"anemia",
",",
"will",
"be",
"allowed",
")"
] | [
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00911560 | 23:26:allergy_name,28:33:allergy_name,35:42:allergy_name,47:53:allergy_name | History of allergy to KLH, QS-21, OPT-821, or glucan | 3 | [
"History",
"of",
"allergy",
"to",
"KLH",
",",
"QS-21",
",",
"OPT-821",
",",
"or",
"glucan"
] | [
0,
0,
0,
0,
4,
0,
4,
0,
4,
0,
0,
4
] |
NCT00909909 | 1:13:treatment,,90:102:treatment,127:146:treatment | Chemotherapy is not administered prior to, during, and for ≥ 21 days after completion of radiotherapy (for patients receiving brachytherapy boost) | 3 | [
"Chemotherapy",
"is",
"not",
"administered",
"prior",
"to",
",",
"during",
",",
"and",
"for",
"≥",
"21",
"days",
"after",
"completion",
"of",
"radiotherapy",
"(",
"for",
"patients",
"receiving",
"brachytherapy",
"boost",
")"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
1,
1,
0
] |
NCT00909909 | 4:29:cancer,69:103:cancer,111:118:cancer,122:130:cancer | No lobular carcinoma in situ alone (i.e., no invasive component) or non-epithelial breast malignancies (e.g., sarcoma or lymphoma) | 3 | [
"No",
"lobular",
"carcinoma",
"in",
"situ",
"alone",
"(",
"i.e.",
",",
"no",
"invasive",
"component",
")",
"or",
"non-epithelial",
"breast",
"malignancies",
"(",
"e.g.",
",",
"sarcoma",
"or",
"lymphoma",
")"
] | [
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
3,
0,
3,
0
] |
NCT00903266 | 48:60:chronic_disease,64:84:chronic_disease,91:99:chronic_disease,101:111:chronic_disease,113:125:chronic_disease | a terminal medical condition; history of major neurological or psychiatric diseases (e.g. epilepsy; meningitis, encephalitis) | 3 | [
"a",
"terminal",
"medical",
"condition",
";",
"history",
"of",
"major",
"neurological",
"or",
"psychiatric",
"diseases",
"(",
"e.g",
".",
"epilepsy",
";",
"meningitis",
",",
"encephalitis",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
2,
0,
2,
0,
2,
0
] |
NCT00896493 | ,,14:50:cancer,,79:104:treatment,131:147:treatment | Stage IIB-IV mycosis fungoides or Sezary syndrome, who have failed at least 1 standard systemic therapy or are not candidates for standard therapy | 3 | [
"Stage",
"IIB-IV",
"mycosis",
"fungoides",
"or",
"Sezary",
"syndrome",
",",
"who",
"have",
"failed",
"at",
"least",
"1",
"standard",
"systemic",
"therapy",
"or",
"are",
"not",
"candidates",
"for",
"standard",
"therapy"
] | [
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT00887146 | 1:8:treatment,21:42:treatment,46:52:treatment, | Surgery (partial or gross total resection or biopsy) must be performed >= 2 weeks prior to registration | 3 | [
"Surgery",
"(",
"partial",
"or",
"gross",
"total",
"resection",
"or",
"biopsy",
")",
"must",
"be",
"performed",
">",
"=",
"2",
"weeks",
"prior",
"to",
"registration"
] | [
1,
0,
0,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00887146 | 7:14:cancer,57:67:cancer,71:100:cancer,117:122:cancer | mixed gliomas are eligible, regardless of the degree of astrocytic or oligodendrocytic predominance, as long as the tumor is also co-deleted for 1p and 19q | 3 | [
"mixed",
"gliomas",
"are",
"eligible",
",",
"regardless",
"of",
"the",
"degree",
"of",
"astrocytic",
"or",
"oligodendrocytic",
"predominance",
",",
"as",
"long",
"as",
"the",
"tumor",
"is",
"also",
"co-deleted",
"for",
"1p",
"and",
"19q"
] | [
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT00881660 | 21:38:treatment,40:58:treatment,63:81:treatment | Contraindication to abdominal surgery, fetoscopic surgery, or general anesthesia | 3 | [
"Contraindication",
"to",
"abdominal",
"surgery",
",",
"fetoscopic",
"surgery",
",",
"or",
"general",
"anesthesia"
] | [
0,
0,
1,
1,
0,
1,
1,
0,
0,
1,
1
] |
NCT00862433 | 20:28:chronic_disease,37:50:chronic_disease,52:71:chronic_disease,,,97:107:chronic_disease,109:134:chronic_disease,137:156:chronic_disease,158:181:chronic_disease,186:213:chronic_disease | Complications from diabetes such as kidney damage (renal insufficiency, serum creatinine >1.8), eye damage (proliferative retinopathy), diabetic neuropathy, coronary artery disease, or peripheral vascular disease | 3 | [
"Complications",
"from",
"diabetes",
"such",
"as",
"kidney",
"damage",
"(",
"renal",
"insufficiency",
",",
"serum",
"creatinine",
">",
"1.8",
")",
",",
"eye",
"damage",
"(",
"proliferative",
"retinopathy",
")",
",",
"diabetic",
"neuropathy",
",",
"coronary",
"artery",
"disease",
",",
"or",
"peripheral",
"vascular",
"disease"
] | [
0,
0,
2,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
2,
2,
2
] |
NCT00862433 | 1:18:chronic_disease,51:64:chronic_disease,66:83:chronic_disease,85:107:chronic_disease,109:122:chronic_disease,124:130:chronic_disease,132:159:chronic_disease | Organ malfunction, including (but not limited to) liver disease, pulmonary disease, ischemic heart disease, heart failure, stroke, peripheral vascular disease | 3 | [
"Organ",
"malfunction",
",",
"including",
"(",
"but",
"not",
"limited",
"to",
")",
"liver",
"disease",
",",
"pulmonary",
"disease",
",",
"ischemic",
"heart",
"disease",
",",
"heart",
"failure",
",",
"stroke",
",",
"peripheral",
"vascular",
"disease"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
2,
0,
2,
2,
2
] |
NCT00857207 | 34:45:treatment,87:102:treatment,104:111:treatment,113:128:treatment,133:147:treatment | Changes within the past month of medications known to affect cognitive functions e.g. benzodiazepines, opioids, antidepressants and antipsychotics | 3 | [
"Changes",
"within",
"the",
"past",
"month",
"of",
"medications",
"known",
"to",
"affect",
"cognitive",
"functions",
"e.g",
".",
"benzodiazepines",
",",
"opioids",
",",
"antidepressants",
"and",
"antipsychotics"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT00819208 | 15:26:treatment,30:32:treatment,42:45:treatment,49:70:treatment,,149:159:cancer,181:193:cancer | Completion of chest x-ray or CT, and CT, MRI or ultrasound of abdomen within 60 days of registration; these imaging tests must not show evidence of metastatic or locally-recurrent colon cancer | 3 | [
"Completion",
"of",
"chest",
"x-ray",
"or",
"CT",
",",
"and",
"CT",
",",
"MRI",
"or",
"ultrasound",
"of",
"abdomen",
"within",
"60",
"days",
"of",
"registration",
";",
"these",
"imaging",
"tests",
"must",
"not",
"show",
"evidence",
"of",
"metastatic",
"or",
"locally-recurrent",
"colon",
"cancer"
] | [
0,
0,
1,
1,
0,
1,
0,
0,
0,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
3,
3
] |
NCT00819208 | 20:43:cancer,64:78:cancer,100:112:cancer,114:130:cancer,135:155:cancer, | adequately treated nonmelanoma skin cancer, curatively treated in situ cancer of the cervix, other solid tumors, Hodgkin lymphoma, or non-Hodgkin lymphoma curatively treated with no evidence of disease for > 5 years | 3 | [
"adequately",
"treated",
"nonmelanoma",
"skin",
"cancer",
",",
"curatively",
"treated",
"in",
"situ",
"cancer",
"of",
"the",
"cervix",
",",
"other",
"solid",
"tumors",
",",
"Hodgkin",
"lymphoma",
",",
"or",
"non-Hodgkin",
"lymphoma",
"curatively",
"treated",
"with",
"no",
"evidence",
"of",
"disease",
"for",
">",
"5",
"years"
] | [
0,
0,
3,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00799864 | 21:25:treatment,60:63:treatment,,108:111:treatment | Any previous use of ARVs with the exception of single dose NVP (Cohort 1 and Cohort 2) or up to 6 weeks of AZT (Cohort 2 only) to prevent mother-to-child transmission (MTCT) | 3 | [
"Any",
"previous",
"use",
"of",
"ARVs",
"with",
"the",
"exception",
"of",
"single",
"dose",
"NVP",
"(",
"Cohort",
"1",
"and",
"Cohort",
"2",
")",
"or",
"up",
"to",
"6",
"weeks",
"of",
"AZT",
"(",
"Cohort",
"2",
"only",
")",
"to",
"prevent",
"mother-to-child",
"transmission",
"(",
"MTCT",
")"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00739362 | 36:39:treatment,47:56:treatment,85:99:chronic_disease | Any conditions contraindicated for MRI (e.g., pacemaker, metal in body, significant claustrophobia) | 3 | [
"Any",
"conditions",
"contraindicated",
"for",
"MRI",
"(",
"e.g.",
",",
"pacemaker",
",",
"metal",
"in",
"body",
",",
"significant",
"claustrophobia",
")"
] | [
0,
0,
0,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
2,
0
] |
NCT00739362 | 11:36:chronic_disease,48:75:chronic_disease,82:97:chronic_disease,102:120:chronic_disease,123:146:chronic_disease,153:167:chronic_disease,170:183:chronic_disease | Diagnosed gastrointestinal diseases, including inflammatory bowel diseases (e.g. Crohn s disease and ulcerative colitis), malabsorption syndromes (e.g. celiac disease), gastric ulcer (active) | 3 | [
"Diagnosed",
"gastrointestinal",
"diseases",
",",
"including",
"inflammatory",
"bowel",
"diseases",
"(",
"e.g",
".",
"Crohn",
"s",
"disease",
"and",
"ulcerative",
"colitis",
")",
",",
"malabsorption",
"syndromes",
"(",
"e.g",
".",
"celiac",
"disease",
")",
",",
"gastric",
"ulcer",
"(",
"active",
")"
] | [
0,
2,
2,
0,
0,
2,
2,
2,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0
] |
NCT00739362 | 1:26:cancer,19:26:cancer,143:166:cancer | non-melanoma skin cancers or cancers that have clearly been cured or, in the opinion of the investigator, carry an excellent prognosis (e.g., Stage 1 cervical cancer) | 3 | [
"non-melanoma",
"skin",
"cancers",
"or",
"cancers",
"that",
"have",
"clearly",
"been",
"cured",
"or",
",",
"in",
"the",
"opinion",
"of",
"the",
"investigator",
",",
"carry",
"an",
"excellent",
"prognosis",
"(",
"e.g.",
",",
"Stage",
"1",
"cervical",
"cancer",
")"
] | [
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0
] |
NCT00734877 | 19:31:chronic_disease,33:50:chronic_disease,69:84:chronic_disease,88:107:chronic_disease,164:173:treatment | Poorly controlled hypertension, diabetes mellitus, or other serious medical illness or psychiatric illness that could potentially interfere with the completion of treatment according to this protocol | 3 | [
"Poorly",
"controlled",
"hypertension",
",",
"diabetes",
"mellitus",
",",
"or",
"other",
"serious",
"medical",
"illness",
"or",
"psychiatric",
"illness",
"that",
"could",
"potentially",
"interfere",
"with",
"the",
"completion",
"of",
"treatment",
"according",
"to",
"this",
"protocol"
] | [
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT00720785 | 1:17:cancer,,,115:126:treatment,130:154:treatment,196:220:chronic_disease | Brain metastases (with the exception of patients with a single brain metastasis less than 1cm treated with either sterotactic or gamma knife radiotherapy) due to poor prognosis and potential for neurological dysfunction that would confound evaluation of neurological and other adverse events) | 3 | [
"Brain",
"metastases",
"(",
"with",
"the",
"exception",
"of",
"patients",
"with",
"a",
"single",
"brain",
"metastasis",
"less",
"than",
"1cm",
"treated",
"with",
"either",
"sterotactic",
"or",
"gamma",
"knife",
"radiotherapy",
")",
"due",
"to",
"poor",
"prognosis",
"and",
"potential",
"for",
"neurological",
"dysfunction",
"that",
"would",
"confound",
"evaluation",
"of",
"neurological",
"and",
"other",
"adverse",
"events",
")"
] | [
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00720785 | 27:50:chronic_disease,52:71:chronic_disease,78:102:treatment | Patients with symptoms of coronary artery disease, cardiac arrhythmias or an abnormal thallium stress test must be evaluated and cleared by cardiology prior to enrollment | 3 | [
"Patients",
"with",
"symptoms",
"of",
"coronary",
"artery",
"disease",
",",
"cardiac",
"arrhythmias",
"or",
"an",
"abnormal",
"thallium",
"stress",
"test",
"must",
"be",
"evaluated",
"and",
"cleared",
"by",
"cardiology",
"prior",
"to",
"enrollment"
] | [
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00719888 | 1:29:cancer,41:68:cancer,72:94:cancer | Acute lymphoblastic leukemia, including biphenotypic acute leukemia or mixed-lineage leukemia | 3 | [
"Acute",
"lymphoblastic",
"leukemia",
",",
"including",
"biphenotypic",
"acute",
"leukemia",
"or",
"mixed-lineage",
"leukemia"
] | [
3,
3,
3,
0,
0,
3,
3,
3,
0,
3,
3
] |
NCT00719888 | 68:98:cancer,,150:164:cancer,168:191:cancer,,345:363:cancer | patients who do not have high-risk features (for example preceding myelodysplastic syndrome [MDS], high-risk cytogenetics, >= 2 cycles to obtain CR, erythroblastic or megakaryocytic leukemia or >= CR2) must be discussed with the principal investigator (PI) prior to enrollment and at the Patient Care Conference or equivalent group such as the pediatric leukemia board as an alternative | 3 | [
"patients",
"who",
"do",
"not",
"have",
"high-risk",
"features",
"(",
"for",
"example",
"preceding",
"myelodysplastic",
"syndrome",
"[",
"MDS",
"]",
",",
"high-risk",
"cytogenetics",
",",
">",
"=",
"2",
"cycles",
"to",
"obtain",
"CR",
",",
"erythroblastic",
"or",
"megakaryocytic",
"leukemia",
"or",
">",
"=",
"CR2",
")",
"must",
"be",
"discussed",
"with",
"the",
"principal",
"investigator",
"(",
"PI",
")",
"prior",
"to",
"enrollment",
"and",
"at",
"the",
"Patient",
"Care",
"Conference",
"or",
"equivalent",
"group",
"such",
"as",
"the",
"pediatric",
"leukemia",
"board",
"as",
"an",
"alternative"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0
] |
NCT00716066 | 15:24:chronic_disease,26:33:chronic_disease,35:42:chronic_disease,46:62:chronic_disease,105:126:treatment | Patients with pulmonary, cardiac, hepatic or renal impairment that would limit their ability to receive cytoreductive therapy and compromise their survival | 3 | [
"Patients",
"with",
"pulmonary",
",",
"cardiac",
",",
"hepatic",
"or",
"renal",
"impairment",
"that",
"would",
"limit",
"their",
"ability",
"to",
"receive",
"cytoreductive",
"therapy",
"and",
"compromise",
"their",
"survival"
] | [
0,
0,
2,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT00715611 | 1:27:treatment,7:27:treatment,36:47:treatment,99:124:treatment,126:146:treatment,148:169:treatment | Prior intrapleural therapy (except pleurodesis) or intrapleural therapy at the time of P/D (i.e.: intrapleural chemotherapy, photodynamic therapy, intrapleural betadine) | 3 | [
"Prior",
"intrapleural",
"therapy",
"(",
"except",
"pleurodesis",
")",
"or",
"intrapleural",
"therapy",
"at",
"the",
"time",
"of",
"P/D",
"(",
"i.e",
".",
":",
"intrapleural",
"chemotherapy",
",",
"photodynamic",
"therapy",
",",
"intrapleural",
"betadine",
")"
] | [
1,
1,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0
] |
NCT00703105 | 1:6:treatment,29:44:treatment,,142:151:treatment | Ontak administration and/or vaccine therapy will commence at least 4 weeks after the completion of the last day of any of the aforementioned therapies | 3 | [
"Ontak",
"administration",
"and/or",
"vaccine",
"therapy",
"will",
"commence",
"at",
"least",
"4",
"weeks",
"after",
"the",
"completion",
"of",
"the",
"last",
"day",
"of",
"any",
"of",
"the",
"aforementioned",
"therapies"
] | [
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT00703105 | 5:16:treatment,44:68:cancer,76:79:cancer,88:93:cancer, | Pre-vaccination the goal is to establish a Minimal Residual Disease state (MRD maximum tumor diameter of any residual disease ≤ 1cm) | 3 | [
"Pre-vaccination",
"the",
"goal",
"is",
"to",
"establish",
"a",
"Minimal",
"Residual",
"Disease",
"state",
"(",
"MRD",
"maximum",
"tumor",
"diameter",
"of",
"any",
"residual",
"disease",
"≤",
"1cm",
")"
] | [
1,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
3,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00673842 | 1:22:chronic_disease,24:36:treatment,40:59:treatment | Chronic renal failure (hemodialysis or peritoneal dialysis) | 3 | [
"Chronic",
"renal",
"failure",
"(",
"hemodialysis",
"or",
"peritoneal",
"dialysis",
")"
] | [
2,
2,
2,
0,
1,
0,
1,
1,
0
] |
NCT00670358 | ,,,84:91:treatment,95:106:treatment,108:121:treatment | Measurable disease, defined as ≥ 1 lesion ≥ 1.5 cm in one diameter, as detected by CT scan or PET-CT scan (PET/CT fusion) | 3 | [
"Measurable",
"disease",
",",
"defined",
"as",
"≥",
"1",
"lesion",
"≥",
"1.5",
"cm",
"in",
"one",
"diameter",
",",
"as",
"detected",
"by",
"CT",
"scan",
"or",
"PET-CT",
"scan",
"(",
"PET/CT",
"fusion",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
1,
1,
0
] |
NCT00670358 | 4:28:chronic_disease,59:66:treatment,88:111:chronic_disease | No congestive heart failure requiring ongoing maintenance therapy for life-threatening ventricular arrhythmias | 3 | [
"No",
"congestive",
"heart",
"failure",
"requiring",
"ongoing",
"maintenance",
"therapy",
"for",
"life-threatening",
"ventricular",
"arrhythmias"
] | [
0,
2,
2,
2,
0,
0,
0,
1,
0,
0,
2,
2
] |
NCT00632853 | 54:72:treatment,89:100:treatment,127:138:treatment,142:151:treatment,156:165:treatment | Patients may have received one and only one cycle of chemotherapy prior to enrolling on CALGB 30610, which must have included carboplatin or cisplatin and etoposide | 3 | [
"Patients",
"may",
"have",
"received",
"one",
"and",
"only",
"one",
"cycle",
"of",
"chemotherapy",
"prior",
"to",
"enrolling",
"on",
"CALGB",
"30610",
",",
"which",
"must",
"have",
"included",
"carboplatin",
"or",
"cisplatin",
"and",
"etoposide"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
0,
1,
0,
1
] |
NCT00630565 | 41:69:chronic_disease,130:134:treatment,141:170:treatment | The patient must be free of symptoms of uncontrolled cardiac disease, and must not have compromised cardiac function detected by ECHO or by gated cardiac blood flow scan | 3 | [
"The",
"patient",
"must",
"be",
"free",
"of",
"symptoms",
"of",
"uncontrolled",
"cardiac",
"disease",
",",
"and",
"must",
"not",
"have",
"compromised",
"cardiac",
"function",
"detected",
"by",
"ECHO",
"or",
"by",
"gated",
"cardiac",
"blood",
"flow",
"scan"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
1,
1,
1
] |
NCT00618683 | 23:40:treatment,51:68:treatment,73:101:chronic_disease | Patient scheduled for electrophysiology study and catheter ablation for supraventricular tachycardia | 3 | [
"Patient",
"scheduled",
"for",
"electrophysiology",
"study",
"and",
"catheter",
"ablation",
"for",
"supraventricular",
"tachycardia"
] | [
0,
0,
0,
1,
0,
0,
1,
1,
0,
2,
2
] |
NCT00594217 | ,,106:109:chronic_disease,114:120:cancer,122:129:cancer,134:152:cancer | women with a history of any disorders that may potentially be complicated by hormonal treatment, such as DVT and breast, ovarian, or endometrial cancer | 3 | [
"women",
"with",
"a",
"history",
"of",
"any",
"disorders",
"that",
"may",
"potentially",
"be",
"complicated",
"by",
"hormonal",
"treatment",
",",
"such",
"as",
"DVT",
"and",
"breast",
",",
"ovarian",
",",
"or",
"endometrial",
"cancer"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
3,
0,
3,
0,
0,
3,
3
] |
NCT00579514 | 50:70:cancer,72:79:cancer,81:87:cancer,89:94:cancer,96:105:cancer,107:112:cancer,114:122:cancer,127:146:cancer,171:179:cancer | MSKCC patients without a histologic diagnosis of cancer of the breast, bladder, kidney, colon, testicles, lungs, prostate, or lymphoid malignancy (including all types of lymphoma) will not be eligible for the AMDeC sponsored component of the study | 3 | [
"MSKCC",
"patients",
"without",
"a",
"histologic",
"diagnosis",
"of",
"cancer",
"of",
"the",
"breast",
",",
"bladder",
",",
"kidney",
",",
"colon",
",",
"testicles",
",",
"lungs",
",",
"prostate",
",",
"or",
"lymphoid",
"malignancy",
"(",
"including",
"all",
"types",
"of",
"lymphoma",
")",
"will",
"not",
"be",
"eligible",
"for",
"the",
"AMDeC",
"sponsored",
"component",
"of",
"the",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
3,
0,
3,
0,
3,
0,
3,
0,
3,
0,
3,
0,
0,
3,
3,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00573027 | 9:31:chronic_disease,64:76:treatment,80:91:treatment | Primary valvular heart disease clearly indicating the need for valve repair or replacement | 3 | [
"Primary",
"valvular",
"heart",
"disease",
"clearly",
"indicating",
"the",
"need",
"for",
"valve",
"repair",
"or",
"replacement"
] | [
0,
2,
2,
2,
0,
0,
0,
0,
0,
1,
1,
0,
1
] |
NCT00539162 | 1:7:cancer,39:51:treatment,55:72:treatment, | Cancer-free and have not received any chemotherapy or radiation therapy for >/=12 months prior to enrolling on this study | 3 | [
"Cancer-free",
"and",
"have",
"not",
"received",
"any",
"chemotherapy",
"or",
"radiation",
"therapy",
"for",
">",
"/=12",
"months",
"prior",
"to",
"enrolling",
"on",
"this",
"study"
] | [
3,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00492778 | 20:41:cancer,52:79:cancer,65:79:cancer,127:150:cancer,152:175:cancer,177:192:cancer,194:220:cancer,222:247:cancer,253:274:cancer | Patients must have endometrial carcinoma including endometrioid adenocarcinoma, adenocarcinoma with squamous differentiation, mucinous adenocarcinoma, squamous cell carcinoma, mixed carcinoma, undifferentiated carcinoma, clear cell adenocarcinoma, and serous adenocarcinoma histologies | 3 | [
"Patients",
"must",
"have",
"endometrial",
"carcinoma",
"including",
"endometrioid",
"adenocarcinoma",
",",
"adenocarcinoma",
"with",
"squamous",
"differentiation",
",",
"mucinous",
"adenocarcinoma",
",",
"squamous",
"cell",
"carcinoma",
",",
"mixed",
"carcinoma",
",",
"undifferentiated",
"carcinoma",
",",
"clear",
"cell",
"adenocarcinoma",
",",
"and",
"serous",
"adenocarcinoma",
"histologies"
] | [
0,
0,
0,
3,
3,
0,
3,
3,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
0,
3,
3,
0,
3,
3,
0,
3,
3,
3,
0,
0,
3,
3,
0
] |
NCT00492778 | 15:35:chronic_disease,49:54:treatment,58:84:treatment | Patients with ureteral obstruction must undergo stent or nephrostomy tube placement prior to study entry | 3 | [
"Patients",
"with",
"ureteral",
"obstruction",
"must",
"undergo",
"stent",
"or",
"nephrostomy",
"tube",
"placement",
"prior",
"to",
"study",
"entry"
] | [
0,
0,
2,
2,
0,
0,
1,
0,
1,
1,
1,
0,
0,
0,
0
] |
NCT00467987 | 1:15:chronic_disease,19:28:treatment,30:51:chronic_disease,53:68:chronic_disease,70:92:treatment,94:101:treatment,105:125:treatment,,, | Coronary event or procedure (myocardial infarction, unstable angina, coronary artery bypass, surgery or coronary angioplasty) in the previous four weeks; 2)Hemoglobin A1c >10% | 3 | [
"Coronary",
"event",
"or",
"procedure",
"(",
"myocardial",
"infarction",
",",
"unstable",
"angina",
",",
"coronary",
"artery",
"bypass",
",",
"surgery",
"or",
"coronary",
"angioplasty",
")",
"in",
"the",
"previous",
"four",
"weeks",
";",
"2",
")",
"Hemoglobin",
"A1c",
">",
"10",
"%"
] | [
2,
2,
0,
1,
0,
2,
2,
0,
2,
2,
0,
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00432094 | ,,,,104:109:treatment,113:119:treatment,,135:143:treatment, | White blood cells (WBC) > 2.5 x 10^9/L with an absolute neutrophile count (ANC) > 1.5 x 10^9/L and off G-CSF or GM-CSF for 10 days or Neulasta for 21 days | 3 | [
"White",
"blood",
"cells",
"(",
"WBC",
")",
">",
"2.5",
"x",
"10^9/L",
"with",
"an",
"absolute",
"neutrophile",
"count",
"(",
"ANC",
")",
">",
"1.5",
"x",
"10^9/L",
"and",
"off",
"G-CSF",
"or",
"GM-CSF",
"for",
"10",
"days",
"or",
"Neulasta",
"for",
"21",
"days"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT00383656 | ,23:46:chronic_disease,70:90:chronic_disease,,142:155:treatment,172:190:chronic_disease | Women and minors with hypothalamic amenorrhea will have a history of secondary amenorrhea of at least six months duration with low or normal gonadotropins or a history of primary amenorrhea in the presence of pulsatile patterns of LH or FAS on baseline frequent sampling studies | 3 | [
"Women",
"and",
"minors",
"with",
"hypothalamic",
"amenorrhea",
"will",
"have",
"a",
"history",
"of",
"secondary",
"amenorrhea",
"of",
"at",
"least",
"six",
"months",
"duration",
"with",
"low",
"or",
"normal",
"gonadotropins",
"or",
"a",
"history",
"of",
"primary",
"amenorrhea",
"in",
"the",
"presence",
"of",
"pulsatile",
"patterns",
"of",
"LH",
"or",
"FAS",
"on",
"baseline",
"frequent",
"sampling",
"studies"
] | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00358657 | 15:31:chronic_disease,79:91:treatment,107:125:treatment, | Patients with fungal pneumonia with radiological progression after receipt of amphotericin formulation or mold-active azoles for greater than 1 month | 3 | [
"Patients",
"with",
"fungal",
"pneumonia",
"with",
"radiological",
"progression",
"after",
"receipt",
"of",
"amphotericin",
"formulation",
"or",
"mold-active",
"azoles",
"for",
"greater",
"than",
"1",
"month"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT00357565 | 1:17:chronic_disease,29:44:treatment,56:72:treatment, | Active infection at time of transplantation (including active infection with Aspergillus or other mold within 30 days) | 3 | [
"Active",
"infection",
"at",
"time",
"of",
"transplantation",
"(",
"including",
"active",
"infection",
"with",
"Aspergillus",
"or",
"other",
"mold",
"within",
"30",
"days",
")"
] | [
2,
2,
0,
0,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00338377 | 5:31:chronic_disease,42:65:treatment,67:88:chronic_disease,104:121:chronic_disease,129:143:chronic_disease,145:156:chronic_disease,160:173:chronic_disease,,,335:347:treatment,348:361:treatment | Any active systemic infections requiring intravenous antibiotics, coagulation disorders or other major medical illnesses of the cardiovascular, respiratory or immune system, such as abnormal stress test and/or abnormal PFT. PI or his designee shall make the final determination regarding appropriateness of enrollment.(Turnstile II - Chemotherapy/Cell Infusion Exclusion Criteria) | 3 | [
"Any",
"active",
"systemic",
"infections",
"requiring",
"intravenous",
"antibiotics",
",",
"coagulation",
"disorders",
"or",
"other",
"major",
"medical",
"illnesses",
"of",
"the",
"cardiovascular",
",",
"respiratory",
"or",
"immune",
"system",
",",
"such",
"as",
"abnormal",
"stress",
"test",
"and/or",
"abnormal",
"PFT",
".",
"PI",
"or",
"his",
"designee",
"shall",
"make",
"the",
"final",
"determination",
"regarding",
"appropriateness",
"of",
"enrollment",
".",
"(",
"Turnstile",
"II",
"-",
"Chemotherapy/Cell",
"Infusion",
"Exclusion",
"Criteria",
")"
] | [
0,
2,
2,
2,
0,
1,
1,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT00338377 | 1:20:treatment,,39:54:chronic_disease,56:87:treatment,91:97:treatment, | MRI/CT of the brain within 42 days of lymphodepletion. CT scan of chest/abdomen/pelvis or PET/CT within 30 days of lymphodepletion | 3 | [
"MRI/CT",
"of",
"the",
"brain",
"within",
"42",
"days",
"of",
"lymphodepletion",
".",
"CT",
"scan",
"of",
"chest/abdomen/pelvis",
"or",
"PET/CT",
"within",
"30",
"days",
"of",
"lymphodepletion"
] | [
1,
1,
1,
1,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT00338377 | 34:47:treatment,40:47:treatment,49:65:treatment,118:134:treatment | Patients previously treated with immunotherapy, targeted therapy, or no therapy will be eligible. Patients receiving cytotoxic agents will be evaluated by the PI or his designee as to suitable eligibility. (Turnstile I) | 3 | [
"Patients",
"previously",
"treated",
"with",
"immunotherapy",
",",
"targeted",
"therapy",
",",
"or",
"no",
"therapy",
"will",
"be",
"eligible",
".",
"Patients",
"receiving",
"cytotoxic",
"agents",
"will",
"be",
"evaluated",
"by",
"the",
"PI",
"or",
"his",
"designee",
"as",
"to",
"suitable",
"eligibility",
".",
"(",
"Turnstile",
"I",
")"
] | [
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |